Close Menu

Changing Biogen

Biogen Idec's new CEO, George Scangos, has a vision to bring new energy and "vitality" to the company and change its culture, says Reuters' Toni Clarke. The former Exelixis CEO wants Biogen to be more flexible — since taking over the company, he has cut costs, focused on priorities in the pipeline, and reorganized the management structure, Clarke says.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Lancet has made changes to its peer-review process in response to its recent retraction of a COVID-19-related paper, Science reports.

The New York Times reports that a series of emails show how Department of Health and Human Services officials sought to silence the Centers for Disease Control and Prevention.

A new initiative aims to move Australia's genome sequencing labs onto one system, the Sydney Morning Herald reports.

In PLOS this week: recessive mutation tied to early-onset dilated cardiomyopathy, epigenetic analysis of lung adenocarcinoma, and more.